跳至主要内容
临床试验/NCT05684133
NCT05684133已完成不适用

REMISE Study: REMnant Biospecimen Investigation in SEpsis

University of Pittsburgh1 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2022年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
71
试验地点
1
主要终点
Difference in traditional biomarkers, proteomics, pathogen sequencing, and metabolomics/lipidomics between prospectively collected biospecimens and remnant biospecimens.

研究概览

简要总结

In the REMISE is study, we will compare blood proteins, biomarkers, and other -omics prospectively collected from patients with sepsis from two sources, i.) remnant (discarded) samples from the clinical laboratory, and ii.) prospectively collected in UPMC Presbyterian hospital research coordinator specimen collected biospecimens.

Analyses will include traditional biomarkers, quantitative proteomics, metabolomics, lipidomics, transcriptomics, and pathogen genomic sequencing in both sets of samples. This data will allow the assessment of the feasibility, integrity, and scientific value of remnant samples compared to research coordinator samples collected at the bedside for mechanistic sepsis research.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient, at least 18 years of age
  • Meeting Sepsis-3 criteria within 6 hours of admission
  • Biospecimens obtained for routine clinical care and measurement
  • Peripheral intravenous access

排除标准

  • Patients who do not have Sepsis-3
  • Traumatic injury,
  • Inability to consent or contact legal representative,
  • Cardiac arrest,
  • Comfort measures only,
  • Unable to obtain intravenous access, and/or
  • Subject declines to participate.
  • No residual blood left in clinical sample

结局指标

主要结局

Difference in traditional biomarkers, proteomics, pathogen sequencing, and metabolomics/lipidomics between prospectively collected biospecimens and remnant biospecimens.

时间窗: 01/2024

次要结局

  • Measurement of traditional biomarkers in all samples(1/2024)
  • Measurement of metabolomics/lipidomics in all samples(1/2024)
  • Measurement of proteomics in all samples(1/2024)
  • Pathogen sequencing in all samples(1/2024)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Seymour

Associate Professor, Dept. of Critical Care Medicine, University of Pittsburgh School of Medicine Associate Professor, Depts. of Emergency Medicine & Clinical Translational Science The CRISMA Center, Director, Translational and Clinical Science Program

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验